Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MRI-Guided High-Definition Transcranial Direct Current Stimulation (tDCS) for Depression

NCT: NCT05090397 · COMPLETED

NCT IDNCT05090397
StatusCOMPLETED
Start Date2023-07-01
Completion2025-03-31
SponsorNorthwestern University (OTHER)
First posted
Last updated

Brief Summary

The purpose of this research is to understand how a neurostimulation technique, transcranial electrical stimulation (tES), affects brain function in adults with major depression measured with functional magnetic resonance imaging (fMRI). This study targets a specific kind of tES called transcranial direct current stimulation (tDCS), where a mild, constant current is passed between electrodes placed on the scalp.

Frequently Asked Questions

What is MRI-Guided High-Definition Transcranial Direct Current Stimulation (tDCS) for Depression?

MRI-Guided High-Definition Transcranial Direct Current Stimulation (tDCS) for Depression is a clinical trial registered under NCT05090397. Current status: COMPLETED.

What is the status of NCT05090397?

The current status of NCT05090397 (MRI-Guided High-Definition Transcranial Direct Current Stimulation (tDCS) for Depression) is: COMPLETED.

When did MRI-Guided High-Definition Transcranial Direct Current Stimulation (tDCS) for Depression start?

MRI-Guided High-Definition Transcranial Direct Current Stimulation (tDCS) for Depression started on 2023-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.